|
Title
|
Published
|
Price
|
|
Good Laboratory And Good Clinical Practice: Requirements For Compliance - Management Involvement And Cost Implications
By: Urch Publishing
The advent of the 'Good Practices', Laboratory and Clinical, has had a direct impact on the pharmaceutical and allied industries since 1976. With the arrival of the new directive governing GCP, the implications have become
|
more...
Search inside this report
|
3/1/2001
|
$72.00
|
|
A Healthy Business Guide to the Pharmaceutical Industry
By: Urch Publishing
A jargon-free guide to the industry and its various components. The guide follows the development of a drug from the early R&D stages through to clinical trials, launch, post marketing and product life-cycle. The author
|
more...
Search inside this report
|
1/1/2001
|
$81.00
|
|
The Billion Dollar Pharmaceutical Club: Profiles of the Leading US Players
By: Urch Publishing
The Billion Dollar Pharmaceutical Club report series provides a unique insight into the leading pharmaceutical manufacturers today. The reports analyse key aspects of the business strategies of over 30 companies and assesses their success by
|
more...
Search inside this report
|
8/1/2000
|
$178.20
|
|
The Billion Dollar Pharmaceutical Club: Profiles of the Leading Japanese Players
By: Urch Publishing
The Billion Dollar Pharmaceutical Club report series provides a unique insight into the leading pharmaceutical manufacturers today. The reports analyse key aspects of the business strategies of over 30 companies and assesses their success by
|
more...
Search inside this report
|
8/1/2000
|
$178.20
|
|
Cost Containment in Healthcare: Putting the Pharmaceutical Industry in Perspective
By: Urch Publishing
This report examines what actions policy-makers, providers and payers have taken to tackle the healthcare problems associtated with an ageing population, rising patient expectations, system inefficiencies, high costs of new drugs and treatments and keeping
|
more...
Buy by the section | Search inside this report
|
8/1/2000
|
$178.20
|
|
The Billion Dollar Pharmaceutical Club: Profiles of the Leading European Players
By: Urch Publishing
The Billion Dollar Pharmaceutical Club report series provides a unique insight into the leading pharmaceutical manufacturers today. The reports analyse key aspects of the business strategies of over 30 companies and assesses their success by
|
more...
Search inside this report
|
9/1/2000
|
$178.20
|
|
Customer-Driven Pharmaceutical Marketing: developing and exploiting profitable relationships
By: Urch Publishing
Something is wrong. Traditional strategies and financial
machinations are being pursued by pharmaceutical
management with decreasingly satisfying results. Mergers
and acquisitions are being consummated with only short-term, ad hoc, quick fix results. Traditional schools
|
more...
Buy by the section | Search inside this report
|
3/30/2001
|
$225.00
|
|
The Pharmaceutical Pricing Compendium - A Practical Guide To The Pricing And Reimbursement Of Medicines
By: Urch Publishing
Pricing and reimbursement is one of the most complicated and important business issues that the pharmaceuticals industry has to deal with.
Setting the right price and ensuring that the product is adequately reimbursed
|
more...
Search inside this report
|
3/1/2003
|
$225.00
|
|
Pharmaceutical Regulation in Europe: An Industry Challenge
By: Urch Publishing
This report provides a thorough analysis of all aspects of pharmaceutical regulation, cutting through complex official documentation to give a clear insight into this complex field. Starting with the very first Community legislation on public
|
more...
Buy by the section | Search inside this report
|
4/1/2000
|
$270.00
|
|
Mergers and Acquisitions in Pharmaceuticals -- Why and How?
By: Urch Publishing
A step by step reference tool to all aspects of mergers and acquisitions. Illustrating the changes from the early days of high margins and large-scale price premiums for innovative high tech acquisitions through to the
|
more...
Buy by the section | Search inside this report
|
2/1/2000
|
$270.00
|
|
EU Accession by Central and Eastern European Countries: Issues for Researched-Based Pharmaceutical Companies
By: Urch Publishing
European Union enlargement to the east brings both threats and opportunities to multinational pharmaceutical companies. This report documents the changes in this sector that will affect all
|
more...
Buy by the section | Search inside this report
|
10/1/2000
|
$306.00
|
|
WTO and Patents -- The Impact on the Pharmaceutical Industry
By: Urch Publishing
Comprehensively reviews patent protection and its role within the global pharmaceutical industry. This unique report assess the importance of the TRIPS framework as a step toward globalisation of legal requirements and reviews the role of
|
more...
Buy by the section | Search inside this report
|
5/1/2000
|
$315.00
|
|
The Future of European Pharmaceutical Distribution
By: Urch Publishing
This report predicts that on-line ordering by pharmacies will encourage entrepreneurial pharmacists to search for cheaper suppliers thereby pressuring distributors margins and encouraging parallel trade.
High amounts of inventory held by pharmaceutical manufacturers is one
|
more...
Buy by the section | Search inside this report
|
4/1/2000
|
$351.00
|
|
Emerging Pharmaceutical Markets - Potential & Problems
By: Urch Publishing
Drug regulators and representatives of the pharmaceutical
industry from the US, Europe and Japan have been
participating for nine years in the International Conference on
Harmonisation (ICH). The purpose is to eliminate duplicative
requirements for
|
more...
Buy by the section | Search inside this report
|
10/26/2001
|
$351.00
|
|
Global Pharmaceutical Pricing - Strategic Issues and Practical Guidelines
By: Urch Publishing
If pricing were not already a core issue for pharmaceutical companies, their customers and payers, the introduction of a single European currency will highlight pricing further, as differences between national markets become more transparent. How
|
more...
|
3/1/2000
|
$358.20
|
|
Patient Groups and the Global Pharmaceutical Industry
By: Urch Publishing
This report gives an overview of the changing dynamics taking place within the pharmaceutical industry world-wide and documents the rise of the patient (consumer) as a potent economic force in healthcare and a prime target
|
more...
Buy by the section | Search inside this report
|
1/1/2000
|
$360.00
|
|
China Pharmaceuticals Guide: New Policy and Regulation
By: Urch Publishing
In a unique collaboration China Concept Consulting, the Chinese Information Centre of The State Drug Administration (SDA) and Informa Pharmaceuticals have prepared the China Pharmaceuticals Guide - a definitive reference manual to the regulation of
|
more...
Buy by the section | Search inside this report
|
6/1/2000
|
$360.00
|
|
New Trends In European Pharmacy
By: Urch Publishing
Pharmacy - the supply of medicines and related products to
the consumer or patient - is undergoing extensive change at
the start of the twentieth-first century. At this time the many
factors that affect it
|
more...
Buy by the section | Search inside this report
|
1/1/2001
|
$360.00
|
|
Drug Discovery: Current Trends and Future Prospects
By: Urch Publishing
This report provides a historical review of drug discovery, and descriptions of the various genomic technologies used in drug discovery, such as genotyping and high-throughput screening (HTS). The report explores technologies used for preparing large
|
more...
Buy by the section | Search inside this report
|
2/1/2001
|
$560.00
|
|
The Pharmaceutical Pricing and Reimbursement Systems of Central and Eastern Europe
By: Urch Publishing
In just ten years many Central and East European (CEE) countries have
brought their pharmaceuticals industry regulation in line with that of the
European Union. Pricing and reimbursement, however, continues to remain a
national issue.
|
more...
Buy by the section | Search inside this report
|
6/24/2002
|
$560.00
|
|
Oligonucleotide Players
By: Urch Publishing
New technological advances in molecular biology have led to the identification of genes associated with major human diseases and to the determination of their genetic basis. Antisense oligonucleotide technology is providing a highly specific strategy
|
more...
Search inside this report
|
4/1/1999
|
$590.00
|
|
Trends in the Plastics Industry
By: Urch Publishing
Highlighting the changes in technological developments, this report reviews all methods of production and processes of monomers like styrene, vinyl chloride, methyl methacrylate and caprolactam and reviews the potential of these materials to reduce the
|
more...
Search inside this report
|
10/1/2000
|
$630.00
|
|
Successful Licensing -- Negotiating and Drafting Optimal Pharmaceutical Deals
By: Urch Publishing
This report provides a comprehensive guide to the business development processes involved in assessing product opportunities, negotiating deals and implementing crucial partnerships.
It shows you how to evaluate the uniqueness of an opportunity, together
|
more...
Search inside this report
|
4/1/1999
|
$675.00
|
|
The Global Supply Chain
By: Urch Publishing
This report examines the conditions that have led to large scale rationalisation and sharp rises in research and development in order to generate superior returns in a patent protected
|
more...
|
3/1/1999
|
$675.00
|
|
Alzheimer's Disease: Current Treatments and Future Prospects
By: Urch Publishing
Already the fourth leading cause of death, it is estimated that there are 8 to 10 million Alzheimer's sufferers in the seven major pharmaceutical markets -the United States, France, Germany, Italy, Spain, the United Kingdom,
|
more...
|
3/1/1999
|
$710.00
|
|
Title
|
Published
|
Price
|